Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series - Commentary

Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)66-67
Number of pages2
JournalInternational Journal of Advances in Rheumatology
Volume9
Issue number2
StatePublished - Dec 1 2011

ASJC Scopus subject areas

  • Rheumatology

Cite this